CHRISTINA COSSOU: Open Payments
NPI 1013459312 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,666 in 118 payments from 16 companies in 2025. Trend: 2023 $2,971 · 2024 $3,128 · 2025 $2,666
Food & beverage: $2,562Education: $104
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $443 |
| ABBVIE INC. | 27 | $438 |
| UCB, Inc. | 10 | $374 |
| Regeneron Healthcare Solutions, Inc. | 3 | $212 |
| Novartis Pharmaceuticals Corporation | 14 | $202 |
| LEO Pharma Inc. | 6 | $190 |
| GENZYME CORPORATION | 7 | $173 |
| Lilly USA, LLC | 6 | $132 |
| Galderma Laboratories, L.P. | 6 | $97 |
| Amgen Inc. | 4 | $95 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, ADBRY, COSENTYX, TALTZ.
Industry payments across MO — which companies pay providers there.
